Title of article :
Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis
Author/Authors :
Goudarzipour, K. shahid beheshti university of medical sciences - Mofid Children’s Hospital, Pediatric Congenital Hematologic Disorders Reaserch Center, تهران, ايران , Kajiyazdi, M. shahid beheshti university of medical sciences - Mofid Children’s Hospital, تهران, ايران , Mahdaviyani, A. shahid beheshti university of medical sciences - Masih Daneshvari Hospital, تهران, ايران
Abstract :
Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment.
Keywords :
X , Linked lymphoproliferative disease , Hemophagocytic lymphohistiocytosis , Systemic inflammatory response syndrome , Infectious mononucleosis , Epstein , Barr virus , Etanercept
Journal title :
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
Journal title :
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
